Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

462 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
BRAFV600E-mutation is invariably present and associated to oncogene-induced senescence in Erdheim-Chester disease.
Cangi MG, Biavasco R, Cavalli G, Grassini G, Dal-Cin E, Campochiaro C, Guglielmi B, Berti A, Lampasona V, von Deimling A, Sabbadini MG, Ferrarini M, Doglioni C, Dagna L. Cangi MG, et al. Among authors: ferrarini m. Ann Rheum Dis. 2015 Aug;74(8):1596-602. doi: 10.1136/annrheumdis-2013-204924. Epub 2014 Mar 26. Ann Rheum Dis. 2015. PMID: 24671772
Tocilizumab in patients with multisystem Erdheim-Chester disease.
Berti A, Cavalli G, Guglielmi B, Biavasco R, Campochiaro C, Tomelleri A, Nicoletti R, Panzacchi A, Ferrarini M, Dagna L. Berti A, et al. Among authors: ferrarini m. Oncoimmunology. 2017 Apr 20;6(6):e1318237. doi: 10.1080/2162402X.2017.1318237. eCollection 2017. Oncoimmunology. 2017. PMID: 28680751 Free PMC article.
Oncogene-induced maladaptive activation of trained immunity in the pathogenesis and treatment of Erdheim-Chester disease.
Molteni R, Biavasco R, Stefanoni D, Nemkov T, Domínguez-Andrés J, Arts RJ, Merelli I, Mazza D, Zambrano S, Panigada M, Cantoni E, Tengesdal IW, Maksud P, Piras F, Cesana D, Cassina L, Distefano G, Loffreda A, Gnani D, De Luca G, Tomelleri A, Campochiaro C, Joosten LAB, Dinarello CA, Kajaste-Rudnitski A, Haroche J, Cardaci S, Cenci S, Dagna L, Doglioni C, Ferrarini M, Ferrero E, Boletta A, D'Alessandro A, Montini E, Netea MG, Cavalli G. Molteni R, et al. Among authors: ferrarini m. Blood. 2021 Oct 28;138(17):1554-1569. doi: 10.1182/blood.2020009594. Blood. 2021. PMID: 34077954 Free article.
Cardiovascular manifestations of Erdheim-Chester disease.
Berti A, Ferrarini M, Ferrero E, Dagna L. Berti A, et al. Among authors: ferrarini m. Clin Exp Rheumatol. 2015 Mar-Apr;33(2 Suppl 89):S-155-63. Epub 2015 Feb 18. Clin Exp Rheumatol. 2015. PMID: 25738753 Review.
Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease.
Diamond EL, Dagna L, Hyman DM, Cavalli G, Janku F, Estrada-Veras J, Ferrarini M, Abdel-Wahab O, Heaney ML, Scheel PJ, Feeley NK, Ferrero E, McClain KL, Vaglio A, Colby T, Arnaud L, Haroche J. Diamond EL, et al. Among authors: ferrarini m. Blood. 2014 Jul 24;124(4):483-92. doi: 10.1182/blood-2014-03-561381. Epub 2014 May 21. Blood. 2014. PMID: 24850756 Free PMC article.
Plasma Chromogranin A as a marker of cardiovascular involvement in Erdheim-Chester disease.
Ferrero E, Corti A, Haroche J, Belloni D, Colombo B, Berti A, Cavalli G, Campochiaro C, Villa A, Cohen-Aubart F, Amoura Z, Doglioni C, Dagna L, Ferrarini M. Ferrero E, et al. Among authors: ferrarini m. Oncoimmunology. 2016 May 5;5(7):e1181244. doi: 10.1080/2162402X.2016.1181244. eCollection 2016 Jul. Oncoimmunology. 2016. PMID: 27622037 Free PMC article.
462 results